Естественные роды и нежная материнская забота. Мудрость и наука о выборе естественных путей беременности, родов и воспитания. Михаил ТитовЧитать онлайн книгу.
a «term cephalic trial’? Aust N Z J Obstet Gynaecol 2003; 43 (5):341—3.
57
Ecker JL. Once a pregnancy, always a cesarean? Rationale and feasibility of a randomized controlled trial. Am J Obstet Gynecol 2004; 190 (2):314—8.
58
National Institute for Clinical Excellence. Caesarean Section Clinical Guidelines. London: National Collaborating Centre for Women’s and Children’s Health, 2004.
59
Buckley SJ. Undisturbed Birth: Nature’s Blueprint for Ease and Ecstasy. Journal of Prenatal and Perinatal Psychology and Health 2003; 17 (4):261— 288. See also Chapter 13.
60
Goodfellow CF, et al. Oxytocin defi ciency at delivery with epidural analgesia. Br J Obstet Gynaecol 1983; 90 (3):214—9.
61
Bacigalupo G, et al. Quantitative relationships between pain intensities during labor and beta-endorphin and cortisol concentrations in plasma. Decline of the hormone concentrations in the early postpartum period. J Perinat Med 1990; 18 (4):289—96.
62
Jones CR, et al. Plasma catecholamines and modes of delivery: the relation between catecholamine levels and in-vitro platelet aggregation and adrenoreceptor radioligand binding characteristics. Br J Obstet Gynaecol 1985; 92 (6):593—9.
63
Krehbiel D, et al. Peridural anesthesia disturbs maternal behavior in primiparous and multiparous parturient ewes. Physiol Behav 1987; 40 (4):463—72.
64
Murray AD, et al. Effects of epidural anesthesia on newborns and their mothers. Child Dev 1981; 52 (1):71—82.
65
Sepkoski CM, et al. The effects of maternal epidural anesthesia on neonatal behavior during the fi rst month. Dev Med Child Neurol 1992; 34 (12):1072—80.
66
Ransjo-Arvidson AB, et al. Maternal analgesia during labor disturbs newborn behavior: effects on breastfeeding, temperature, and crying. Birth 2001; 28 (1):5—12.
67
Rosenblatt DB, et al. The infl uence of maternal analgesia on neonatal behaviour: II. Epidural bupivacaine. Br J Obstet Gynaecol 1981; 88 (4):407—13.
68
Murray AD, et al. Effects of epidural anesthesia on newborns and their mothers. Child Dev 1981; 52 (1):71—82.
69
Golub MS. Labor analgesia and infant brain development. Pharmacol Biochem Behav 1996; 55 (4):619—28.
70
Enkin M, et al. Effective Care in Pregnancy and Childbirth. 3rd edn. Oxford: Oxford University Press, 2000, p 486.
71
Kelly J, Bean C. Australian Attitudes. Sydney: Allen and Unwin, 1988.
72
Biggio JR, Jr., et al. An outcomes analysis of fi ve prenatal screening strategies for trisomy 21 in women younger than 35 years. Am J Obstet Gynecol 2004; 190 (3):721—9.
73
Mulvey S, Wallace EM. Levels of knowledge of Down syndrome and Down syndrome testing in Australian women. Aust N Z J Obstet Gynaecol 2001; 41 (2):167—9.
74
Rostant K, et al. Survey of the knowledge, attitudes and experiences of Western Australian women in relation to prenatal screening and diagnostic procedures. Aust N Z J Obstet Gynaecol 2003; 43 (2):134—8.
75
Sadler M. Serum screening for Down’s syndrome: how much do health professionals know? Br J Obstet Gynaecol 1997; 104 (2):176—9.
76
Tyzack K, Wallace EM. Down syndrome screening: what do health professionals know? Aust N Z J Obstet Gynaecol 2003; 43 (3):217—21.
77
Carroll JC, et al. Ontario Maternal Serum Screening Program: practices, knowledge and opinions of health care providers. Can Med Assoc J 1997; 156 (6):775—84.
78
Wertz D. Drawing lines: notes for policymakers. In: Parens E, Asch A, eds. Prenatal testing and Disability Rights. Washington DC: Georgetown University Press, 2000:44—53.
79
de Crespigny L, Dredge R. Which Tests for my Unborn Baby? – Ultrasound and other prenatal tests. 2nd edn. Melbourne: Oxford University Press, 1996.
80
Cheng PJ, et al. Elevated maternal midtrimester serum free beta-human chorionic gonadotropin levels in vegetarian pregnancies that cause increased false-positive Down syndrome screening results. Am J Obstet Gynecol 2004; 190 (2):442—7.
81
Spencer K, et al. The impact of correcting for smoking status when screening for chromosomal anomalies using maternal serum biochemistry and fetal nuchal translucency thickness in the first trimester of pregnancy. Prenat Diagn 2004; 24 (3):169—73.
82
Watt HC, et al. Effect of allowing for ethnic group in prenatal screening for Down’s syndrome. Prenat Diagn 1996; 16 (8):691—8.
83
Abdul-Hamid S, et al. Maternal serum screening for trisomy 21 in women with a false positive result in last pregnancy. J Obstet Gynaecol 2004; 24 (4):374—6.
84
Spong CY, et al. Risk of abnormal triple screen for Down syndrome is signifi cantly higher in patients with female fetuses. Prenat Diagn 1999; 19 (4):337—9.
85
Wald NJ, et al. Maternal serum screening for Down’s syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight. Br J Obstet Gynaecol 1992; 99 (2):144—9.
86
Wapner R, et al. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003; 349 (15):1405—13.
87
Wald NJ, et al. SURUSS in perspective. Br J Obstet Gynaecol 2004; 111 (6):521—31.
88
UK National Screening Programmes Committee Programmes Directorate. Screening for Down’s syndrome: Model of best practice (Appendix 3). In: National Down’s Syndrome Screening Programme for England. Oxford: UK National Screening Programmes Committee Programmes Directorate, 2004 www.nelh.nhs.uk/screening/dssp/Handbook_fi nal. pdf
89
Royal Australian and New Zealand College of Obstetricians and